CN106967132A - Reactive compound and its preparation method and application in Shenzhou City's honey peach - Google Patents
Reactive compound and its preparation method and application in Shenzhou City's honey peach Download PDFInfo
- Publication number
- CN106967132A CN106967132A CN201710207665.3A CN201710207665A CN106967132A CN 106967132 A CN106967132 A CN 106967132A CN 201710207665 A CN201710207665 A CN 201710207665A CN 106967132 A CN106967132 A CN 106967132A
- Authority
- CN
- China
- Prior art keywords
- compound
- honey peach
- methanol
- shenzhou
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000006040 Prunus persica var persica Nutrition 0.000 title claims abstract description 37
- 150000001875 compounds Chemical class 0.000 title claims abstract description 33
- 235000012907 honey Nutrition 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 240000006413 Prunus persica var. persica Species 0.000 title 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 69
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 31
- 230000003712 anti-aging effect Effects 0.000 claims abstract description 18
- 239000000284 extract Substances 0.000 claims abstract description 8
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 4
- 238000001914 filtration Methods 0.000 claims abstract 2
- 229940125904 compound 1 Drugs 0.000 claims description 29
- 229940125782 compound 2 Drugs 0.000 claims description 22
- 238000000926 separation method Methods 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 8
- 239000003480 eluent Substances 0.000 claims description 6
- 230000014759 maintenance of location Effects 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 230000036541 health Effects 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 claims description 2
- 238000004007 reversed phase HPLC Methods 0.000 claims description 2
- 239000003125 aqueous solvent Substances 0.000 claims 4
- 238000010828 elution Methods 0.000 claims 2
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract description 40
- 238000004458 analytical method Methods 0.000 abstract description 8
- 210000005253 yeast cell Anatomy 0.000 abstract description 7
- 101150017120 sod gene Proteins 0.000 abstract description 6
- 230000007246 mechanism Effects 0.000 abstract description 5
- 230000036542 oxidative stress Effects 0.000 abstract description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 230000004083 survival effect Effects 0.000 abstract description 4
- 238000012360 testing method Methods 0.000 abstract description 4
- 229930182470 glycoside Natural products 0.000 abstract description 3
- 239000002547 new drug Substances 0.000 abstract description 2
- 238000009509 drug development Methods 0.000 abstract 1
- 150000002338 glycosides Chemical class 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- RXHIKAIVEMAPRU-JRIGQVHBSA-N sequiterpene Natural products C1=C(C)[C@@H](OC(C)=O)[C@H](O)[C@@]2(O)[C@H](C)CC[C@@H](C(C)=C)[C@H]21 RXHIKAIVEMAPRU-JRIGQVHBSA-N 0.000 abstract 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 38
- 239000000843 powder Substances 0.000 description 13
- 230000032683 aging Effects 0.000 description 12
- 230000003362 replicative effect Effects 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 9
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 235000021283 resveratrol Nutrition 0.000 description 9
- 229940016667 resveratrol Drugs 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 238000005481 NMR spectroscopy Methods 0.000 description 8
- 239000013641 positive control Substances 0.000 description 8
- 239000013642 negative control Substances 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 239000001888 Peptone Substances 0.000 description 6
- 108010080698 Peptones Proteins 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 235000019319 peptone Nutrition 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 240000005809 Prunus persica Species 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 238000001425 electrospray ionisation time-of-flight mass spectrometry Methods 0.000 description 4
- 238000001819 mass spectrum Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- -1 sesquiterpene glycoside compound Chemical class 0.000 description 3
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 239000006481 glucose medium Substances 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000401 methanolic extract Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229950008882 polysorbate Drugs 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- LUKBXSAWLPMMSZ-UHFFFAOYSA-N resveratrol Chemical compound C1=CC(O)=CC=C1C=CC1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-UHFFFAOYSA-N 0.000 description 2
- 229930004725 sesquiterpene Natural products 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 240000002381 Prunus davidiana Species 0.000 description 1
- 235000015533 Prunus davidiana Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000255588 Tephritidae Species 0.000 description 1
- YSVZGWAJIHWNQK-UHFFFAOYSA-N [3-(hydroxymethyl)-2-bicyclo[2.2.1]heptanyl]methanol Chemical compound C1CC2C(CO)C(CO)C1C2 YSVZGWAJIHWNQK-UHFFFAOYSA-N 0.000 description 1
- 229940124532 absorption promoter Drugs 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000012059 conventional drug carrier Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000007919 dispersible tablet Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 238000003919 heteronuclear multiple bond coherence Methods 0.000 description 1
- 238000005570 heteronuclear single quantum coherence Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
- C07H1/08—Separation; Purification from natural products
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
技术领域technical field
本发明涉及医药技术领域,尤其涉及深州蜜桃中的两种活性化合物及其制备方法和应用。The invention relates to the technical field of medicines, in particular to two active compounds in Shenzhou honey peach and its preparation method and application.
背景技术Background technique
根据最新统计数据,全世界60岁及以上老龄人口在2014年已经达到了9.01亿,预计到2050年这个数字将会超过20亿。世界已进入老龄化社会,随之而来的与衰老相关的疾病已成为日益显著的问题,包括阿尔茨海默病、帕金森在内的神经退行性疾病是世界性的医学难题之一。仅在中国,阿尔茨海默病的患者数量在2010年已增加至569万。在医药学领域,寻找防治老年性疾病的药物已经成为当务之急。According to the latest statistics, the number of people aged 60 and above in the world reached 901 million in 2014, and this number is expected to exceed 2 billion by 2050. The world has entered an aging society, and the accompanying diseases related to aging have become increasingly significant problems. Neurodegenerative diseases including Alzheimer's disease and Parkinson's disease are one of the worldwide medical problems. In China alone, the number of patients with Alzheimer's disease has increased to 5.69 million in 2010. In the field of medicine, finding medicines for preventing and treating senile diseases has become a top priority.
经过对衰老机制的长期研究,本领域内已形成多种衰老学说,包括程序衰老说、体细胞突变说、错误成灾说,自由基说、神经内分泌说、免疫衰老说等等。由此可见,衰老是一个十分复杂的过程,即便是同一类抗衰老药物,其发挥药效的方式也不尽相同,彼此之间无必然联系。After long-term research on the mechanism of aging, a variety of aging theories have been formed in this field, including the theory of programmed aging, somatic cell mutation, error disaster, free radical theory, neuroendocrine theory, immune aging theory and so on. It can be seen that aging is a very complicated process. Even the same type of anti-aging drugs have different ways of exerting their effects, and there is no necessary connection between them.
深州蜜桃来源于河北省深州市,此地具有独特的地理环境和土壤条件,盛产蜜桃,特色鲜明。深州市也被国家林业局命名为“中国蜜桃之乡”。深州蜜桃个头硕大、果型独特、色泽绚丽、果顶凸尖、缝合线深、皮薄肉细、汁甜如蜜、香味浓郁等独特的风味特色,被誉为桃中之王,又称魁桃。历经两千多年,一直作为皇室贡品,是独有的名贵品种,史称“贡桃”。Shenzhou peaches come from Shenzhou City, Hebei Province. This place has a unique geographical environment and soil conditions. It is rich in peaches and has distinctive characteristics. Shenzhou City was also named "Hometown of Chinese Peach" by the State Forestry Administration. Shenzhou peaches are huge in size, unique in shape, gorgeous in color, protruding at the top of the fruit, deep in suture, thin in skin and thin in flesh, sweet as honey in juice, and rich in fragrance. They are known as the king of peaches, also known as Kui Tao. After more than two thousand years, it has been used as a tribute to the royal family. It is a unique and precious variety, known as "tribute peach" in history.
发明内容Contents of the invention
本发明的目的是提供一种深州蜜桃中的活性化合物1(化合物SZMT01)和化合物2,所述的深州蜜桃中的活性化合物为倍半萜苷类化合物,其中化合物1为倍半萜酯苷类新结构化合物,两种活性化合物具有较强的抗衰老能力。其结构式如下:The object of the present invention is to provide a kind of active compound 1 (compound SZMT01) and compound 2 in Shenzhou honey peach, the active compound in described Shenzhou honey peach is sesquiterpene glycoside compound, and wherein compound 1 is sesquiterpene A new structure compound of terpene glycosides, two active compounds have strong anti-aging ability. Its structural formula is as follows:
上述深州蜜桃活性化合物1的理化性质为:无色粉末;(c 0.16,MeOH);分子式为C21H34O8;高分辨率质谱ESI-TOF-MS m/z 437.2151[M+Na]+,理论值::C21H34O8Na+437.2151;1H和13C NMR如表1所示。The physical and chemical properties of the above Shenzhou peach active compound 1 are: colorless powder; (c 0.16, MeOH); molecular formula is C 21 H 34 O 8 ; high resolution mass spectrum ESI-TOF-MS m/z 437.2151[M+Na] + , theoretical value: C 21 H 34 O 8 Na + 437.2151; 1 H and 13 C NMR are shown in Table 1.
活性化合物2的理化性质为:无色粉末;(c 0.2,MeOH);分子式为C21H36O7;高分辨率质谱ESI-TOF-MS m/z 423.2368[M+Na]+,理论值:C21H36O7Na+423.2359;13CNMR(125MHz,CD3CD)数据如下:δC 14.1(C-13),16.0(C-14),23.7(C-8),27.4(C-4),27.6(C-15),40.3(C-5),43.4(C-9),62.8(C-6′),71.8(C-4′),73.9(C-10),75.1(C-2′),76.0(C-1),77.9(C-5′),78.2(C-3′),102.6(C-1′),112.0(C-12),126.0(C-7),129.9(C-3),132.9(C-2),135.7(C-6),146.4(C-11)。The physical and chemical properties of active compound 2 are: colorless powder; (c 0.2, MeOH); molecular formula is C 21 H 36 O 7 ; high resolution mass spectrum ESI-TOF-MS m/z 423.2368[M+Na] + , theoretical value: C 21 H 36 O 7 Na + 423.2359; 13 CNMR (125MHz, CD 3 CD) data are as follows: δ C 14.1(C-13), 16.0(C-14), 23.7(C-8), 27.4(C-4), 27.6(C-15), 40.3( C-5), 43.4(C-9), 62.8(C-6′), 71.8(C-4′), 73.9(C-10), 75.1(C-2′), 76.0(C-1), 77.9 (C-5′), 78.2 (C-3′), 102.6 (C-1′), 112.0 (C-12), 126.0 (C-7), 129.9 (C-3), 132.9 (C-2 ), 135.7 (C-6), 146.4 (C-11).
本发明的另一个目的是提供深州蜜桃中两个活性化合物1(化合物SZMT01)和化合物2的制备方法,通过以下步骤实现:Another object of the present invention is to provide the preparation method of two active compounds 1 (compound SZMT01) and compound 2 in Shenzhou honey peach, realize through the following steps:
(1)取深州蜜桃果实,粉碎后,置于甲醇中浸提,过滤浓缩,获得浸提物;(1) Take the Shenzhou peach fruit, crush it, place it in methanol for extraction, filter and concentrate to obtain the extract;
(2)对浸提物进行分离纯化,获得所述深州蜜桃活性化合物1和化合物2。(2) Separating and purifying the extract to obtain the Shenzhou peach active compound 1 and compound 2.
作为优选,步骤(1)中,所述浸提的温度为25~30℃,时间为0.5~24h。更优选,所述浸提的温度为25℃室温,时间为24h。Preferably, in step (1), the temperature of the leaching is 25-30° C., and the time is 0.5-24 h. More preferably, the temperature of the leaching is 25° C. at room temperature, and the time is 24 hours.
进一步地,步骤(2)中,所述分离纯化的过程包括:Further, in step (2), the process of said separation and purification includes:
(a)以甲醇:水溶剂系统作洗脱剂,对浸提物进行第一次分离,获得目标馏分I;(a) using methanol: water solvent system as eluent, the extract is separated for the first time to obtain target fraction I;
(b)以甲醇:水溶剂系统作洗脱剂,对所述目标馏分I进行第二次分离,获得活性馏分II和活性馏分III;(b) using methanol: water solvent system as eluent, the target fraction I is separated for the second time to obtain active fraction II and active fraction III;
(c)以甲醇水溶液为流动相,利用反相HPLC对活性馏分II和活性馏分III进行第三次分离,获得所述深州蜜桃活性化合物1和化合物2;(c) Using methanol aqueous solution as mobile phase, utilize reversed-phase HPLC to separate active fraction II and active fraction III for the third time to obtain the Shenzhou peach active compound 1 and compound 2;
其中:步骤(a)中,采用十八烷基键合硅胶开口柱进行分离;甲醇:水溶剂系统按体积比30:70,50:50,70:30,100:0依次洗脱,体积比70:30洗脱的馏分为目标馏分I。Wherein: in step (a), an octadecyl bonded silica gel open column is used for separation; methanol: water solvent system is eluted sequentially at a volume ratio of 30:70, 50:50, 70:30, and 100:0, and the volume ratio is 70: The 30 eluted fraction is the target fraction I.
步骤(b)中,采用十八烷基键合硅胶开口柱进行分离;甲醇:水溶剂系统按照体积比50:50,55:45,60:40,65:35,70:30,80:20,100:0依次洗脱,体积比60:40和65:35洗脱的馏分为活性馏分II和活性馏分III。In step (b), use octadecyl bonded silica gel open column for separation; methanol: water solvent system according to the volume ratio of 50:50,55:45,60:40,65:35,70:30,80:20,100 :0 eluted in turn, the volume ratio 60:40 and 65:35 eluted fractions were active fraction II and active fraction III.
步骤(c)中,所述流动相为63%甲醇水溶液;分离过程中,取保留时间为13.9分钟的馏分,得到深州蜜桃活性化合物1。In step (c), the mobile phase is 63% methanol aqueous solution; during the separation process, the fraction with a retention time of 13.9 minutes is taken to obtain Shenzhou Peach active compound 1.
步骤(c)中,所述流动相为65%甲醇水溶液;分离过程中,取保留时间为14.5分钟的馏分,得到深州蜜桃活性化合物2。In the step (c), the mobile phase is 65% methanol aqueous solution; during the separation process, the fraction with a retention time of 14.5 minutes is taken to obtain Shenzhou Peach active compound 2.
本发明的再一个目的是提供所述深州蜜桃活性化合物在制备抗衰老药物或保健品中的应用,例如将深州蜜桃制成抗衰老蜜桃饮品等。由深州蜜桃活性化合物和药学上可接受的载体制成。研究表明,化合物SZMT01和化合物2在抗衰老化合物的体外筛选模型中,均可以显著延长酵母细胞的复制性寿命。Another object of the present invention is to provide the application of the active compound of Shenzhou peach in the preparation of anti-aging medicine or health products, for example, making Shenzhou peach into an anti-aging peach drink. Made from deep state peach active compounds and pharmaceutically acceptable carriers. Studies have shown that both compound SZMT01 and compound 2 can significantly prolong the replicative lifespan of yeast cells in the in vitro screening model of anti-aging compounds.
所述药学上可接受的载体是指药学领域常规的药物载体,如填充剂、粘合剂、湿润剂、吸收促进剂、表面活性剂等。The pharmaceutically acceptable carrier refers to conventional drug carriers in the pharmaceutical field, such as fillers, adhesives, wetting agents, absorption promoters, surfactants and the like.
所述填充剂可采用淀粉、蔗糖或微晶纤维素;所述粘合剂可采用淀粉浆、羟丙纤维素、明胶或聚乙二醇;所述湿润剂可采用硬脂酸镁、微粉硅胶或聚乙二醇类;所述吸收促进剂可采用聚山梨脂或卵磷脂;所述表面活性剂可采用伯洛沙姆、脂肪酸山梨坦或聚山梨脂。另外还可以加入其它辅剂如香味剂、甜味剂等。The filler can adopt starch, sucrose or microcrystalline cellulose; the binder can adopt starch slurry, hydroxypropyl cellulose, gelatin or polyethylene glycol; the wetting agent can adopt magnesium stearate, micropowder silica gel Or polyethylene glycols; the absorption enhancer can use polysorbate or lecithin; the surfactant can use boloxamer, fatty acid sorbitan or polysorbate. In addition, other adjuvants such as flavoring agents and sweetening agents can also be added.
所述抗衰老药物或保健品的剂型可以是片剂,丸剂,粉剂,分散片,小药囊剂,酏剂,混悬剂,乳剂,溶液剂,糖浆剂,气雾剂,软胶囊,硬胶囊,无菌注射液,搽剂或栓剂;可制成常规、速释、缓释或延迟释放制剂。The dosage form of described anti-aging medicine or health product can be tablet, pill, powder, dispersible tablet, sachet, elixir, suspension, emulsion, solution, syrup, aerosol, soft capsule, hard capsule Capsules, sterile injectable solutions, liniments or suppositories; available in conventional, immediate-release, sustained-release or delayed-release formulations.
本发明的抗衰老药物可通过各种途径给予,包括口服、鼻腔、肌肉注射、皮下注射、静脉注射等。The anti-aging medicine of the present invention can be administered through various routes, including oral administration, nasal cavity injection, intramuscular injection, subcutaneous injection, intravenous injection and the like.
为了进一步探究化合物SZMT01在抗衰老方面的作用机理,我们通过氧化应激实验对化合物SZMT01进行了抗衰老机理初步研究,发现该化合物SZMT01在双氧水存在的条件下可以提高酵母的生存率,同时也发现该化合物是通过调节SOD基因的表达,提高酵母的抗氧化能力,从而实现酵母细胞复制性寿命的延长的。In order to further explore the anti-aging mechanism of compound SZMT01, we conducted a preliminary study on the anti-aging mechanism of compound SZMT01 through oxidative stress experiments, and found that the compound SZMT01 can improve the survival rate of yeast in the presence of hydrogen peroxide, and also found that The compound improves the antioxidant capacity of yeast by regulating the expression of SOD gene, thereby prolonging the replicative lifespan of yeast cells.
根据氧化自由基学说,氧化压力是导致衰老的主要原因。即使在正常条件下线粒体也会产生有害的代谢产物—活性氧(ROS),这些物质会破坏细胞膜和生物大分子,例如蛋白和核酸,进而破坏细胞的功能,引起衰老和死亡。According to the oxidative free radical theory, oxidative stress is the main cause of aging. Even under normal conditions, mitochondria can produce harmful metabolites—reactive oxygen species (ROS), which can damage cell membranes and biomacromolecules, such as proteins and nucleic acids, thereby disrupting cell functions, causing aging and death.
SOD是一个与抗氧化应激相关的基因。化合物SZMT01不能延长SOD敲除后的酵母的复制性寿命,进而证明SZMT01是通过调节SOD基因的表达,从而实现酵母细胞复制性寿命的延长的。SOD is a gene associated with resistance to oxidative stress. The compound SZMT01 could not prolong the replicative lifespan of the SOD-knockout yeast, which further proves that SZMT01 prolongs the replicative lifespan of yeast cells by regulating the expression of the SOD gene.
与现有技术相比,本发明具有以下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
(1)在酵母衰老模型K6001酿酒酵母细胞中,本发明从深州蜜桃中提取出的化合物SZMT01和2能够显著延长酵母细胞的复制性寿命,具有很强的抗衰老能力。(1) In the yeast aging model K6001 Saccharomyces cerevisiae cells, the compounds SZMT01 and 2 extracted from Shenzhou peach in the present invention can significantly prolong the replicative lifespan of yeast cells and have strong anti-aging ability.
(2)本发明深州蜜桃活性化合物对延缓衰老及治疗衰老性疾病方面的新药研发进行基础性研究,具有重要的现实意义。(2) The Shenzhou Peach active compound of the present invention has important practical significance for basic research on the research and development of new drugs for delaying aging and treating senile diseases.
附图说明Description of drawings
图1为实施例2中制备获得的深州蜜桃活性化合物1(A)和化合物2(B)对酵母K6001复制性寿命的影响结果;其中,Control表示阴性对照;Res(Resveratrol)为阳性对照白藜芦醇(10μM);1 7.5μM表示浓度为7.5μM的化合物1,1 25μM表示浓度为25μM的化合物1;27.5μM表示浓度为7.5μM的化合物2,2 25μM表示浓度为25μM的化合物2。Fig. 1 is the effect result of Shenzhou peach active compound 1 (A) and compound 2 (B) obtained in embodiment 2 on yeast K6001 replicative lifespan; Wherein, Control represents negative control; Res (Resveratrol) is positive control Resveratrol (10 μM); 1 7.5 μM indicates compound 1 at a concentration of 7.5 μM, 1 25 μM indicates compound 1 at a concentration of 25 μM; 27.5 μM indicates compound 2 at a concentration of 7.5 μM, 2 25 μM indicates compound 2 at a concentration of 25 μM .
图2为实施例3中活性化合物1对酵母突变菌株Δsod1(A)和Δsod2(B)复制性寿命的影响结果;其中,Control(K6001)表示未添加活性化合物1的K6001酵母;Control(Δsod1)和Control(Δsod2)分别表示未添加活性化合物1的K6001酵母突变菌株Δsod1和Δsod2;1 7.5μM(Δsod1)和1 7.5μM(Δsod2)分别表示添加7.5μM活性化合物1的K6001酵母突变菌株Δsod1和Δsod2。Fig. 2 is the result of the effect of active compound 1 on the replicative lifespan of yeast mutant strains Δsod1 (A) and Δsod2 (B) in Example 3; wherein, Control (K6001) represents the K6001 yeast without adding active compound 1; Control (Δsod1) and Control(Δsod2) respectively represent K6001 yeast mutant strains Δsod1 and Δsod2 without adding active compound 1; .
图3为实施例3中活性化合物1氧化应激实验结果;其中,Control(K6001)表示未添加活性化合物1的K6001酵母;Control表示阴性对照;Res(Resveratrol)为阳性对照白藜芦醇(10μM);1 7.5μM表示浓度为7.5μM的化合物1,1 25μM表示浓度为25μM的化合物1。Fig. 3 is the oxidative stress test result of active compound 1 in embodiment 3; Wherein, Control (K6001) represents the K6001 yeast that does not add active compound 1; Control represents negative control; Res (Resveratrol) is positive control resveratrol (10 μ M ); 1 7.5 μM indicates compound 1 at a concentration of 7.5 μM, and 1 25 μM indicates compound 1 at a concentration of 25 μM.
具体实施方式detailed description
本发明结合附图和实施例做进一步的说明。The present invention is further described in conjunction with drawings and embodiments.
实施例1Example 1
1、深州蜜桃中活性化合物1和化合物2的制备,具体步骤如下:1. The preparation of active compound 1 and compound 2 in Shenzhou honey peach, the specific steps are as follows:
(1)将3.0kg深州蜜桃置于甲醇(工业级)中,室温下浸提24小时(震荡);经抽滤浓缩后,得到甲醇浸提物100.0g。(1) Put 3.0 kg of Shenzhou peaches in methanol (industrial grade) and extract at room temperature for 24 hours (shaking); after concentrated by suction filtration, 100.0 g of methanol extracts were obtained.
(2)将甲醇浸提物用十八烷基键合硅胶开口柱进行分离,以甲醇:水溶剂系统作洗脱剂,按甲醇:水的体积比=30:70,50:50,70:30,100:0,依次洗脱,取体积比70:30洗脱的馏分0.7g。(2) Separating the methanol extract with an octadecyl bonded silica gel open column, using methanol:water solvent system as eluent, according to the volume ratio of methanol:water=30:70,50:50,70: 30,100:0, eluted in sequence, and 0.7g of the fraction eluted with a volume ratio of 70:30 was taken.
(3)将步骤(2)所取馏分用十八烷基键合硅胶开口柱进行纯化,以甲醇∶水溶剂系统作洗脱剂,按甲醇∶水的体积比=50:50,55:45,60:40,65:35,70:30,80:20,100:0依次洗脱,取体积比60:40和65:35分别洗脱的馏分3.7mg和2.3mg。(3) Purify the fraction obtained in step (2) with an open column of octadecyl bonded silica gel, using methanol: water solvent system as eluent, according to the volume ratio of methanol: water = 50:50, 55:45 , 60:40, 65:35, 70:30, 80:20, and 100:0 were eluted in sequence, and 3.7 mg and 2.3 mg of fractions eluted at volume ratios of 60:40 and 65:35 were taken.
(4)取步骤(3)所取馏分,用反向HPLC纯化,色谱条件:色谱柱ODS-HG-5(10/250mm),流速3ml/min,检测波长210nm,流动相为63%甲醇水溶液,得到活性化合物1 1.1mg(保留时间为13.9min);流动相为65%甲醇水溶液,得到活性化合物2 1.8mg(保留时间为14.5min)。2、活性化合物1和化合物2的理化特征及化学结构分析(4) Get the cut that step (3) takes, purify with reverse HPLC, chromatographic condition: chromatographic column ODS-HG-5 (10/250mm), flow rate 3ml/min, detection wavelength 210nm, mobile phase is 63% aqueous methanol , to obtain 1.1 mg of active compound 1 (retention time of 13.9 min); the mobile phase was 65% aqueous methanol, and 1.8 mg of active compound 2 was obtained (retention time of 14.5 min). 2. Physical and chemical characteristics and chemical structure analysis of active compound 1 and compound 2
经13C NMR、1H NMR、HRMS、HSQC、HMBC、NOESY分析,结果如下:After 13 C NMR, 1 H NMR, HRMS, HSQC, HMBC, NOESY analysis, the results are as follows:
化合物1的理化性质:无色粉末,分子式为C21H34O8,高分辨率质谱ESI-TOF-MS m/z437.2151[M+Na]+。1H NMR和13C NMR的数据见下表1。Physical and chemical properties of compound 1: colorless powder, molecular formula C 21 H 34 O 8 , high-resolution mass spectrum ESI-TOF-MS m/z 437.2151[M+Na] + . 1 H NMR and 13 C NMR data are shown in Table 1 below.
表1 11H NMR和13C NMR数据(CD3OD;δ/ppm,J/Hz).Table 1 1 1 H NMR and 13 C NMR data (CD 3 OD; δ/ppm, J/Hz).
a500MHz,b125MHz a 500MHz, b 125MHz
化合物2的理化性质:无色粉末,分子式为C21H36O7;高分辨率质谱ESI-TOF-MS m/z423.2368[M+Na]+。13C NMR(125MHz,CD3CD)数据如下:δC 14.1(C-13),16.0(C-14),23.7(C-8),27.4(C-4),27.6(C-15),40.3(C-5),43.4(C-9),62.8(C-6′),71.8(C-4′),73.9(C-10),75.1(C-2′),76.0(C-1),77.9(C-5′),78.2(C-3′),102.6(C-1′),112.0(C-12),126.0(C-7),129.9(C-3),132.9(C-2),135.7(C-6),146.4(C-11)。Physicochemical properties of compound 2: colorless powder, molecular formula C 21 H 36 O 7 ; high-resolution mass spectrum ESI-TOF-MS m/z 423.2368[M+Na] + . 13 C NMR (125MHz, CD 3 CD) data are as follows: δC 14.1( C -13), 16.0(C-14), 23.7(C-8), 27.4(C-4), 27.6(C-15), 40.3 (C-5), 43.4 (C-9), 62.8 (C-6′), 71.8 (C-4′), 73.9 (C-10), 75.1 (C-2′), 76.0 (C-1 ), 77.9 (C-5′), 78.2 (C-3′), 102.6 (C-1′), 112.0 (C-12), 126.0 (C-7), 129.9 (C-3), 132.9 (C -2), 135.7(C-6), 146.4(C-11).
化合物1和化合物2的结构式如下;The structural formulas of compound 1 and compound 2 are as follows;
实施例2深州蜜桃中活性化合物1(SZMT01)和化合物2的抗衰老活性分析Anti-aging activity analysis of active compound 1 (SZMT01) and compound 2 in Shenzhou honey peach in embodiment 2
目前,用于抗衰老研究的生物模型主要有老鼠,线虫,果蝇和酵母。本实施例选择酿酒酵母作为抗衰老研究的活性系统;因为酵母是单细胞的真核生物,生命周期短,已获其完整的基因组数据,是目前常用的衰老模型生物。At present, the biological models used for anti-aging research mainly include mice, nematodes, fruit flies and yeast. In this example, Saccharomyces cerevisiae was selected as the active system for anti-aging research; because yeast is a single-celled eukaryote with a short life cycle, its complete genome data has been obtained, and it is currently a commonly used aging model organism.
与此同时,以白藜芦醇作为阳性对照,白藜芦醇是目前众所周知的、在多种动物模型上显示抗衰老作用的小分子化合物。At the same time, resveratrol is used as a positive control, which is a well-known small molecular compound that shows anti-aging effects in various animal models.
分析方法的步骤如下:The steps of the analysis method are as follows:
(1)从-30℃冰箱取出K6001酵母菌株,用PBS洗涤三次,每次5ml,除去其中的甘油;再加入1ml PBS,吹打,使其悬浮后加入到5ml液体培养基(1%的酵母粉,2%的蛋白胨,3%的半乳糖)中;28℃振摇(160r/min)培养24小时。(1) Take out the K6001 yeast strain from the refrigerator at -30°C, wash it three times with PBS, 5ml each time, and remove the glycerol therein; then add 1ml PBS, pipette to suspend it, and then add it to 5ml liquid medium (1% yeast powder , 2% peptone, 3% galactose); cultured at 28° C. for 24 hours with shaking (160 r/min).
(2)培养结束后,用5ml PBS洗涤三次,除去其中的液体培养基,用血球计数板计数,计算酵母的浓度。(2) After the cultivation, wash three times with 5ml PBS, remove the liquid medium therein, count with a hemocytometer, and calculate the concentration of yeast.
(3)采用无水乙醇作溶剂,配制7.5μM,25μM的1和2,10μM的白藜芦醇,备用。(3) Using absolute ethanol as a solvent, prepare 7.5 μM, 25 μM 1 and 2, and 10 μM resveratrol for later use.
(4)在灭菌的培养皿中加入5ml的固体培养基(1%的酵母粉,2%的蛋白胨,2%的葡萄糖,2%的琼脂粉),待培养基凝固后,向其中分别加入步骤(3)中配制好的样品,溶剂挥发后加入4000个酵母,用涂布器涂抹均匀,28℃恒温培养48小时。(4) Add 5ml of solid medium (1% yeast powder, 2% peptone, 2% glucose, 2% agar powder) to the sterilized petri dish. After the medium solidifies, add For the sample prepared in step (3), 4,000 yeasts were added after the solvent evaporated, spread evenly with a spreader, and incubated at a constant temperature of 28°C for 48 hours.
(5)显微镜下每皿随机数出40个母细胞分别产生的子细胞个数,并记录、作图分析,结果见图1。(5) Randomly count the number of daughter cells produced by 40 mother cells in each plate under the microscope, record, draw and analyze. The results are shown in Figure 1.
由图1可知,阴性对照(未添加样品,Control)的平均寿命为7.10±0.34,阳性对照(添加10μM的白藜芦醇,Resverstrol)是8.40±0.47*;7.5μM,25μM浓度的1分别是8.87±0.53**,8.37±0.51*;7.5μM,25μM浓度的2分别是8.40±0.54*,8.20±0.41*。(*p<0.05,**p<0.01).As can be seen from Figure 1, the average lifespan of the negative control (no sample added, Control) is 7.10 ± 0.34, and that of the positive control (10 μM resveratrol, Resverstrol) is 8.40 ± 0.47*; 7.5 μM and 25 μM concentrations of 1 are 8.87±0.53**, 8.37±0.51*; 7.5μM, 25μM concentrations of 2 were 8.40±0.54*, 8.20±0.41*, respectively. (*p<0.05,**p<0.01).
因此,化合物1和化合物2能延长酵母的复制性寿命。Therefore, Compound 1 and Compound 2 can prolong the replicative lifespan of yeast.
实施例3深州蜜桃中活性化合物1抗衰老机制分析Example 3 Anti-aging Mechanism Analysis of Active Compound 1 in Shenzhou Peach
1、测试1在7.5μM的活性浓度下是否能够延长敲除了SOD基因的K6001酵母突变菌株Δsod1和Δsod2的复制性寿命。1. To test whether 1 can prolong the replicative lifespan of K6001 yeast mutant strains Δsod1 and Δsod2 with the SOD gene knocked out at an active concentration of 7.5 μM.
分析方法的步骤如下:The steps of the analysis method are as follows:
(1)从-30℃冰箱取出K6001酵母菌株和K6001酵母突变菌株Δsod1和Δsod2,用PBS洗涤三次,每次5ml,除去其中的甘油;再加入1ml PBS,吹打,使其悬浮后加入到5ml液体培养基(1%的酵母粉,2%的蛋白胨,3%的半乳糖)中;28℃振摇(160r/min)培养24小时。(1) Take out the K6001 yeast strain and the K6001 yeast mutant strains Δsod1 and Δsod2 from the -30°C refrigerator, wash with PBS three times, 5ml each time, and remove the glycerol; then add 1ml of PBS, pipette to suspend, and then add to 5ml of liquid culture medium (1% yeast powder, 2% peptone, 3% galactose); cultured at 28° C. with shaking (160 r/min) for 24 hours.
(2)培养结束后,用5ml PBS洗涤三次,除去其中的液体培养基,用血球计数板计数,计算酵母的浓度。(2) After the cultivation, wash three times with 5ml PBS, remove the liquid medium therein, count with a hemocytometer, and calculate the concentration of yeast.
(3)采用无水乙醇作溶剂,配制7.5μM的1,备用。(3) Using absolute ethanol as a solvent, prepare 7.5 μM of 1 and set aside.
(4)在灭菌的培养皿中加入5ml的固体培养基(1%的酵母粉,2%的蛋白胨,2%的葡萄糖,2%的琼脂粉),待培养基凝固后,向其中分别加入步骤(3)中配制好的样品,溶剂挥发后。加入4000个酵母(K6001酵母菌株或者K6001酵母突变菌株Δsod1和Δsod2,用涂布器涂抹均匀,28℃恒温培养48小时。(4) Add 5ml of solid medium (1% yeast powder, 2% peptone, 2% glucose, 2% agar powder) to the sterilized petri dish. After the medium solidifies, add The sample prepared in step (3), after the solvent evaporates. Add 4000 yeasts (K6001 yeast strain or K6001 yeast mutant strains Δsod1 and Δsod2, spread evenly with a spreader, and incubate at a constant temperature of 28°C for 48 hours.
(5)显微镜下每皿随机数出40个母细胞分别产生的子细胞个数,并记录、作图分析,结果见图2。(5) Randomly count the number of daughter cells produced by 40 mother cells in each plate under the microscope, record, draw and analyze. The results are shown in Figure 2.
由图2可知,K6001菌株上阴性对照(未添加样品,Control)的平均寿命为6.85±0.42,阳性对照(添加10μM的白藜芦醇,Resverstrol)是8.70±0.48**,7.5μM浓度的1是8.40±0.48*;K6001酵母突变菌株Δsod1上阴性对照(未添加样品,Control)的平均寿命为6.55±0.33,阳性对照(添加10μM的白藜芦醇,Resverstrol)是6.95±0.32,7.5μM浓度的1是7.05±0.37;K6001酵母突变菌株Δsod2上阴性对照(未添加样品,Control)的平均寿命为6.65±0.36,阳性对照(添加10μM的白藜芦醇,Resverstrol)是7.17±0.46,7.5μM浓度的1是7.25±0.32。(*p<0.05,**p<0.01)It can be seen from Figure 2 that the average lifespan of the negative control (no sample added, Control) on the K6001 strain was 6.85±0.42, and the positive control (10 μM resveratrol, Resverstrol) was 8.70±0.48**, 7.5 μM concentration of 1 is 8.40±0.48*; the average lifespan of the negative control (no sample added, Control) on the K6001 yeast mutant strain Δsod1 is 6.55±0.33, and the positive control (10 μM resveratrol, Resverstrol) is 6.95±0.32, 7.5 μM concentration 1 is 7.05±0.37; the average lifespan of the negative control (no sample added, Control) on the K6001 yeast mutant strain Δsod2 is 6.65±0.36, and the positive control (10 μM resveratrol, Resverstrol) is 7.17±0.46, 7.5 μM The concentration of 1 is 7.25 ± 0.32. (*p<0.05,**p<0.01)
因此,化合物1在7.5μM的活性浓度下不能够延长敲除了SOD基因的K6001酵母突变菌株Δsod1和Δsod2的复制性寿命。Therefore, Compound 1 was unable to prolong the replicative lifespan of K6001 yeast mutant strains Δsod1 and Δsod2 in which the SOD gene was knocked out at an active concentration of 7.5 μM.
实施例5SZMT01提高酵母生存率的活性分析Embodiment 5 SZMT01 improves the activity analysis of yeast viability
测试SZMT01能否提高酵母的生存率,测试方法如下:To test whether SZMT01 can improve the survival rate of yeast, the test method is as follows:
(1)将-30℃保存的野生型酵母BY4741用5ml PBS洗涤三次,除去其中的甘油;加入1ml无菌水,吹打使其悬浮,加入到5ml葡萄糖培养基(1%的酵母粉,2%的蛋白胨,2%的葡萄糖)中;将其放入摇床,28℃振摇(160r/min)培养24小时,使其恢复生长能力。(1) Wash the wild-type yeast BY4741 stored at -30°C with 5ml PBS three times to remove the glycerol; add 1ml sterile water, blow it to suspend it, add it to 5ml glucose medium (1% yeast powder, 2% peptone, 2% glucose); put it into a shaker, and shake (160r/min) at 28°C for 24 hours to restore its growth ability.
(2)将BY4741接种到25mL新的葡萄糖培养基,调整OD600值为0.1,然后分别与7.5μM、25μM的胆固醇和阳性对照品(10μM的白藜芦醇,Resverstrol)孵育12小时。(2) Inoculate BY4741 into 25 mL of new glucose medium, adjust the OD 600 value to 0.1, and then incubate with 7.5 μM, 25 μM cholesterol and positive control substance (10 μM resveratrol, Resverstrol) for 12 hours.
(3)取各组含有相同酵母细胞的培养液5μL滴在含有9mM H2O2的葡萄糖固体培养基(1%的酵母粉,2%的蛋白胨,2%的葡萄糖,2%琼脂)上;28℃培养3天后观察酵母的生长状况并照相,观察结果见图3。(3) 5 μL of culture solution containing the same yeast cells in each group was dropped on glucose solid medium (1% yeast powder, 2% peptone, 2% glucose, 2% agar) containing 9mM H 2 O 2 ; After culturing at 28°C for 3 days, the growth status of the yeast was observed and photographed, and the observation results are shown in Figure 3.
由图3可见,与阴性对照相比,在含有9mM H2O2的葡萄糖固体培养基上,7.5μM、25μM的SZMT01明显提高了酵母的生存率。It can be seen from Figure 3 that compared with the negative control, 7.5 μM and 25 μM SZMT01 significantly increased the survival rate of yeast on the glucose solid medium containing 9mM H 2 O 2 .
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710207665.3A CN106967132B (en) | 2017-03-31 | 2017-03-31 | Reactive compound and its preparation method and application in Shenzhou City's honey peach |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710207665.3A CN106967132B (en) | 2017-03-31 | 2017-03-31 | Reactive compound and its preparation method and application in Shenzhou City's honey peach |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106967132A true CN106967132A (en) | 2017-07-21 |
CN106967132B CN106967132B (en) | 2019-05-21 |
Family
ID=59336439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710207665.3A Active CN106967132B (en) | 2017-03-31 | 2017-03-31 | Reactive compound and its preparation method and application in Shenzhou City's honey peach |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106967132B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113088394A (en) * | 2021-04-26 | 2021-07-09 | 江苏省农业科学院 | Zhongzhou honey peach essence |
-
2017
- 2017-03-31 CN CN201710207665.3A patent/CN106967132B/en active Active
Non-Patent Citations (2)
Title |
---|
MACAHIG, RENE ANGELO等: "Glucosylated sesquiterpene alcohols from Fraxinus Glucosylated sesquiterpene alcohols from Fraxinus", 《NATURAL PRODUCT COMMUNICATIONS》 * |
XI, FENG-MIN等: "Thiophenes, polyacetylenes and terpenes from the aerial parts of Eclipta prostrata", 《BIOORGANIC & MEDICINAL CHEMISTRY》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113088394A (en) * | 2021-04-26 | 2021-07-09 | 江苏省农业科学院 | Zhongzhou honey peach essence |
CN113088394B (en) * | 2021-04-26 | 2024-02-13 | 江苏省农业科学院 | Honey peach essence |
Also Published As
Publication number | Publication date |
---|---|
CN106967132B (en) | 2019-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102070695B (en) | Preparation and application of ergosterol derivatives | |
CN105859816B (en) | Method, application and the product of Sitosterolum and β daucosterols are extracted in fructus cannabis | |
US20040162246A1 (en) | Medicinal preparation containing phenylethanoid glycosides extracted from herbaceous plant, cistanche tubulosa (schenk.) wight, process of making the same, and uses of the same | |
EP2324840B1 (en) | Production of caffeoylquinic acids from plant cell cultures of echinacea angustifolia | |
CN111961022B (en) | A kind of biflavonoid compound with neuroprotective effect and its extraction and separation method | |
CN102603818B (en) | Preparation method and use of cerebroside compounds | |
CN103360452B (en) | The Synthesis and applications of Muskmelon Base tetracyclic triterpene cucurbitane compound | |
CN102370635B (en) | Application and preparation method of novel nardosinone | |
CN111153908B (en) | Azophilic ketone alkaloid with anti-tumor activity, preparation method and application thereof | |
CN106967132A (en) | Reactive compound and its preparation method and application in Shenzhou City's honey peach | |
CN102250197B (en) | Preparation method and application of total steroidal saponin extracts of dwarf lilyturf roots | |
CN103342730B (en) | Preparation method of extract of traditional Chinese medicine herb of manyflower ticklover and use of the extract in anti-aging | |
CN105640937A (en) | Application of dehydrogenation zaluzanin C | |
CN114621094B (en) | Compound with islet protection function and preparation method and application thereof | |
CN102002081A (en) | 9-O-beta-D-glucosyl nandinine as well as preparation method and application thereof | |
CN107686501B (en) | Extraction method of cucurbitane-type triterpenoids and its anti-aging medicinal use | |
CN103275138B (en) | Sixteen carbon diacetylated no double bond lactone type sophorolipid and its application | |
CN106336433B (en) | A kind of arabidopsis active component extract and its preparation method and application | |
CN103275139B (en) | 16 carbon diacetyl one double bond lactone type sophorolipid and application thereof | |
CN103204860B (en) | Amaryllidaceae Alkaloids with Neuroprotective Effects | |
US20230404946A1 (en) | Use of (5r,7r,10r)-12,15-dioxo-alpha-selinene in the preparation of drugs | |
CN114456053A (en) | Benzaldehyde compound produced by marine fungi, preparation method and anti-inflammatory application thereof | |
CN105585573A (en) | Tropolone compound, pharmaceutical composition thereof as well as preparation method and applications of tropolone compound | |
CN104398524B (en) | Mussel steroid active component extract, preparation method and applications thereof | |
CN103275140B (en) | The two key lactone type sophorolipids of 18 one of carbon diacetyl and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231023 Address after: No.98 Baoheng Road, Shenzhou City, Hengshui City, Hebei Province, 052800 Patentee after: Hebei Kaixiang Health Technology Co.,Ltd. Address before: 310058 Yuhang Tang Road, Xihu District, Hangzhou, Zhejiang 866 Patentee before: ZHEJIANG University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240529 Address after: No. 55 Shunda North Street, Shenzhou City, Hengshui City, Hebei Province, 053899 Patentee after: Yihe (Shenzhou) Life and Health Research Institute Country or region after: China Address before: No.98 Baoheng Road, Shenzhou City, Hengshui City, Hebei Province, 052800 Patentee before: Hebei Kaixiang Health Technology Co.,Ltd. Country or region before: China |